The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization

Cell Death and Disease

Volumn 4, Issue 10, 2013, Pages

  Wang, C ^a   Lv, X ^a   He, C ^a   Hua, G ^a   Tsai, M Y ^a   Davis, J S ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

Apoptosis; Cell proliferation; G 1; GPER; Ovarian cancer

Indexed keywords

(1 [4 (6 BROMOBENZO[1,3] DIOXOL 5YL) 3A,4,5,9B TETRAHYDRO 3H CYCLOPENTA[C]QUINOLIN 8 YL] ETHANONE; ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR AGONIST; G PROTEIN COUPLED RECEPTOR 30; UNCLASSIFIED DRUG; VINCA ALKALOID;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROTUBULE; MICROTUBULE ASSEMBLY; MITOSIS; OVARY CANCER; PRIORITY JOURNAL; PROPHASE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOPENTANES; FEMALE; HUMANS; OVARIAN NEOPLASMS; POLYMERIZATION; PROPHASE; QUINOLINES; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SPINDLE APPARATUS; SUS SCROFA; TUBULIN;

EID: 84887456860     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.397     Document Type: Article

References (39)

1. Prossnitz ER, Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 2011; 7: 715-726
2. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest 2006; 116: 561-570
3. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2006; 2: 207-212
4. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK et al. In vivo effects of a GPR30 antagonist. Nat Chem Biol 2009; 5: 421-427
5. Dennis MK, Field AS, Burai R, Ramesh C, Petrie WK, Bologa CG et al. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J Steroid Biochem Mol Biol 2011; 127: 358-366
6. Blasko E, Haskell CA, Leung S, Gualtieri G, Halks-Miller M, Mahmoudi M et al. Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J Neuroimmunol 2009; 214: 67-77
7. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A et al. G protein coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17betaestradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 2007; 67: 1859-1866
8. Madeo A, Maggiolini M. Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. Cancer Res 2010; 70: 6036-6046
9. Pandey DP, Lappano R, Albanito L, Madeo A, Maggiolini M, Picard D. Estrogenic GPR30 signaling induces proliferation and migration of breast cancer cells through CTGF. EMBO J 2009; 28: 523-532
10. He YY, Cai B, Yang YX, Liu XL, Wan XP. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. Cancer Sci 2009; 100: 1051-1061
11. Chevalier N, Vega A, Bouskine A, Siddeek B, Michiels JF, Chevallier D et al. GPR30, the non-classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation. PLoS One 2012; 7: E34672
12. Du GQ, Zhou L, Chen XY, Wan XP, He YY. The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells. Biochem Biophys Res Commun 2012; 420: 343-349
13. Chan QK, Lam HM, Ng CF, Lee AY, Chan ES, Ng HK et al. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fosdependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death Differ 2010; 17: 1511-1523
14. Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE et al. The G proteincoupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res 2010; 70: 1184-1194
15. Wang C, Prossnitz ER, Roy SK. GPR30 expression is required for estrogen stimulation of primordial follicle formation in the hamster ovary. Endocrinology 149: 4452-4461 2008
16. Wang C, Prossnitz ER, Roy SK. Expression of GPR30 in hamster ovary: Differential regulation by gonadotropins and steroids hormones. Endocrinology 2007; 148: 4853-4864
17. Pang Y, Thomas P. Role of G protein-coupled estrogen receptor 1, GPER, in inhibition of oocyte maturation by endogenous estrogens in zebrafish. Dev Biol 2010; 342: 194-206
18. Heublein S, Lenhard M, Vrekoussis T, Schoepfer J, Kuhn C, Friese K et al. The G-protein coupled estrogen receptor (GPER) is expressed in normal human ovaries and is upregulated in ovarian endometriosis and pelvic inflammatory disease involving the ovary. Reprod Sci 2012; 19: 1197-1204
19. Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ et al. GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol 2009; 114: 465-471
20. Hans F, Dimitrov S. Histone H3 phosphorylation and cell division. Oncogene 2001; 20: 3021-3027
21. Kolkova Z, Casslén V, Henic E, Ahmadi S, Ehinger A, Jirström K et al. The G proteincoupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer. J Ova Res 2012; 5: 9
22. Preuss U, Landsberg G, Scheidtmann KH. Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by Dlk/ZIP kinase. Nucleic Acids Res 2003; 31: 878-885
23. Fukasawa K. Oncogenes and tumor suppressors take on centrosomes. Nat Rev Cancer 2007; 7: 911-924
24. Albanito L, Lappano R, Madeo A, Chimento A, Prossnitz ER, Cappello AR et al. G-protein-coupled receptor 30 and estrogen receptor a are involved in the proliferative effects induced by atrazine in ovarian cancer cells. Environ Health Perspect 2008; 116: 1648-1655
25. Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A et al. 17b-estradiol, genistein and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G-protein-coupled receptor GPR30. Mol Pharmacol 2006; 70: 1414-1423
26. Chevalier N, Bouskine A, Fenichel P. Bisphenol A promotes testicular seminoma cell proliferation through GPER, the G-protein-coupled estrogen receptor. Int J Cancer 2012; 130: 241-242
27. Dong S, Terasaka S, Kiyama R. Bisphenol A induces a rapid activation of Erk1/2 through GPR30 in human breast cancer cells. Environ Pollut 2011; 159: 212-218
28. Wang C, Lv XM, Jiang C, Davis JS. The putative G-protein coupled estrogen receptor (GPER) agonist G-1 suppresses proliferation of ovarian and breast cancer cells in a GPERindependent manner. Am J Transl Res 2012; 4: 390-402
29. Holm A, Grände PO, Ludueña RF, Olde B, Prasad V, Leeb-Lundberg LM et al. The G protein-coupled oestrogen receptor 1 agonist G-1 disrupts endothelial cell microtubule structure in a receptor-independent manner. Mol Cell Biochem 2012; 366: 239-249
30. Satoh MS, Lindahl T. Role of poly(ADP-ribose) formation in DNA repair. Nature 1992; 356: 356-358
31. Oliver FJ, De La Rubia G, Rolli V, Ruiz-Ruiz MC, De Murcia G, Murcia JM. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 1998; 273: 33533-33539
32. Bennett V, Gilligan DM. The spectrin-based membrane skeleton and micron-scale organization of the plasma membrane. Annu Rev Cell Biol 1993; 9: 27-66
33. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53: 3976-3985
34. Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999; 6: 1028-1042
35. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, EarnshawWC. Cleavage of poly(ADPribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371: 346-347
36. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43
37. Cregan SP, Dawson VL, Slack RS. Role of AIF in caspase-dependent and caspaseindependent cell death. Oncogene 2004; 23: 2785-2796
38. Boutros R, Lobjois V, Ducommun B. CDC25 phosphatases in cancer cells: Key players? Good targets? Nat Rev Cancer 2007; 7: 495-507
39. Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 2007; 8: 379-393 Development